Gene · 10288
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population. | J Alzheimers Dis Rep | 2023 | 38025799 | PubTator, text mining | PubMed |
| Human leukocyte immunoglobulin-like receptors in health and disease. | Front Immunol | 2023 | 38022598 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy. | Front Immunol | 2023 | 38022518 | PubTator, text mining | PubMed |
| Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. | Front Aging Neurosci | 2023 | 38020773 | PubTator, text mining | PubMed |
| Chronological aging impacts abundance, function and microRNA content of extracellular vesicles produced by human epidermal keratinocytes. | Aging (Albany NY) | 2023 | 38015712 | PubTator, text mining | PubMed |
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| The Role of Gluten in Food Products and Dietary Restriction: Exploring the Potential for Restoring Immune Tolerance. | Foods | 2023 | 38002235 | PubTator, text mining | PubMed |
| Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. | J Transl Med | 2023 | 37978542 | PubTator, text mining | PubMed |
| A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. | Cancer Cell Int | 2023 | 37974212 | PubTator, text mining | PubMed |
| Molecular markers that predict response to combined radiotherapy and immunotherapy in patients with lung adenocarcinoma: a bioinformatics analysis. | Transl Cancer Res | 2023 | 37969379 | PubTator, text mining | PubMed |
| Molecular and Cellular Mechanisms of Osteoporosis. | Int J Mol Sci | 2023 | 37958752 | PubTator, text mining | PubMed |
| The Tumorigenicity of Breast Cancer Cells Is Reduced upon Treatment with Small Extracellular Vesicles Isolated from Heparin Treated Cell Cultures. | Int J Mol Sci | 2023 | 37958720 | PubTator, text mining | PubMed |
| CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37958404 | PubTator, text mining | PubMed |
| Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. | Hum Vaccin Immunother | 2023 | 37947202 | PubTator, text mining | PubMed |
| Bioinformatics analyses of potentially common pathogenic networks for primary Sjögren's syndrome complicated with acute myocardial infarction. | Sci Rep | 2023 | 37935719 | PubTator, text mining | PubMed |
| Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases. | Front Immunol | 2023 | 37928540 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in meningitis patients with reactivated varicella zoster virus. | Immun Inflamm Dis | 2023 | 37904697 | PubTator, text mining | PubMed |
| Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer. | World J Gastroenterol | 2023 | 37899785 | PubTator, text mining | PubMed |
| Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model. | Sci Rep | 2023 | 37898651 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10288/papers?page=8